ClinicalXchange Internal Medicine podcasts

Join a multidisciplinary panel including Dr. Jim Gavin, Dr. Steve Vacalis, and Dr. Jodi Strong as they discuss and share their insights on the issues surrounding therapeutic inertia. They will also evaluate when to use a GLP-1 RA, and a clinical trial comparing the efficacy and safety of a GLP-1 RA versus a DPP-4i.

Join this multidisciplinary discussion with Jim Gavin, MD; Curtis Triplitt, PharmD; and Jeffrey Unger, MD, as they review the mechanism of action, dosing, efficacy, and safety of a once-daily GLP-1 RA for adult patients with T2D.

Listen as Dr Neil Skolnik and Nurse Practitioner Corinne Young uncover the burden of COPD exacerbations, and speak to their experiences in managing patients with COPD. This podcast will help in generating an appreciation of the range of associated consequences to the patient.

Join leaders in the field of diabetes Dr. Jim Gavin, Dr. Pablo Mora, and Dr. Bob Busch as they navigate through a clinical study. What do you need to know about using a GLP-1 RA for glycemic control with patients who have T2D? Are there any considerations for specific populations such as those who have moderate renal impairment?

Episode #7: Join experts in T2D: Dr John Anderson (primary care provider), Ms Lucia Novak (Nurse Practitioner), and Dr Joshua Stolker (cardiologist) as they talk about ways to think differently about type 2 diabetes and consider factors in addition to A1C. This podcast is sponsored by Novo Nordisk and is intended for clinicians.

Episode #6: Drs John Anderson, Pam Taub, and Mark Greathouse review the relationship between type 2 diabetes (T2D) and cardiovascular disease (CVD), including how T2D exacerbates CVD and the risk from CVD, and what the national medical associations recommend for patients with T2D and CVD. This podcast is sponsored by Novo Nordisk and is intended for clinicians.

Join experts in T2D: Dr John Anderson, Dr Javier Morales, and Dr Richard Pratley as they review the impact of insufficient GLP-1 activity in patients with T2D. This podcast is sponsored by Novo Nordisk and is intended for clinicians.

One-fourth of American adults take lipid-lowering statin medications

Episode #4:

Join multidisciplinary experts in T2D: Dr John Anderson, Dr Vivian Fonseca, and Dr Jim Gavin as they discuss the fascinating history of GLP-1 discovery and the role of endogenous GLP-1 in the pathophysiology of T2D. This podcast is sponsored by Novo Nordisk and is intended for Healthcare Practitioners.

Episode #3:

Join primary care experts in T2D: Dr. John Anderson, Dr. Stephen Brunton and Dr. James LaSalle as we discuss the beta-cell function and its critical role in T2D pathogenesis.